Novo Holdings — Full Portfolio

Avalyn Pharma develops inhaled therapies for pulmonary fibrosis, using a nebulization approach that delivers treatment directly to the lungs to reduce the tolerability problems of existing oral therapies.

BiotechHealthtech

LBLyn Baranowski(CEO)in

Co-investorsANAndera PartnersCACatalio Capital Management, LPF-F-Prime CapitalINInVivium CapitalNONorwest Venture PartnersPIPivotal Life Sciences+9 more

Bolt Biotherapeutics is a clinical-stage biotech company developing novel immunotherapies that leverage innate immune system mechanisms to treat cancer.

BiotechHealthtechMedical DevicesSan Francisco, US

DEDr. Edgar G. Engleman(Founder)

Co-investorsPFPfizer Venture InvestmentsPIPivotal Life SciencesRARA CapitalSASamsara BioCapitalSOSofinnova VenturesVIVivo Capital+3 more

Damora Therapeutics is a preclinical-stage biotechnology company that discovers and develops therapeutic candidates, including DMR-001, DMR-002, and DMR-003, with the goal of advancing treatments through investigational drug applications and clinical trials.

BiotechCopenhagen, US

GWGarrett Winslow(Executive Officer)inLFLori Firmani(Executive Officer)inHans T. Schambye(Executive Officer, Director)Jennifer Jarrett(President, Chief Executive Officer and Director)inBecker Hewes(Chief Medical Officer)Sherwin Sattarzadeh(Chief Operating Officer)

Co-investorsACAccess BiotechnologyVIViking GlobalANAndreessen HorowitzBABAM ElevateBABay City CapitalCOCommodore Capital+8 more

Disc Medicine is a biopharmaceutical company developing therapies from discovery through clinical development for patients in need.

BiotechHealthtech

JQJohn Quisel(Chief Executive Officer)inJFJean Franchi(Chief Financial Officer)inJYJonathan Yu(Chief Operating Officer)inWSWill Savage(Chief Medical Officer)inPSPamela Stephenson(Chief Commercial Officer)inSCSteve Caffé(Chief Regulatory Officer)in

Co-investorsACAccess BiotechnologyATAtlas VentureBABain Capital Life SciencesFOForesite CapitalFRFrazier Life SciencesOROrbiMed+7 more

Edgewise Therapeutics discovers and develops small molecule medicines targeting muscle proteins to treat neuromuscular and cardiac diseases, including sevasemten for muscular dystrophies and EDG-7500 for cardiomyopathy, leveraging a proprietary drug discovery platform based on muscle physiology and high-throughput functional assays.

BiotechDigital HealthBoulder, US

Kevin Koch(Executive Officer, Director)inARAlan Russell(Director)inBEBadreddin Edris(Director and Co-Founder)inKHKenneth Harrison(Director)

BoardPTPeter Thompson(Director)inJRJonathan Root(Director)in

Co-investorsBOBoulder VenturesFOForesite CapitalOROrbiMedUSUS Venture PartnersVIViking GlobalWEWellington Management+1 more

Harmony Biosciences develops innovative therapeutic treatments focused on rare neurological diseases.

BiotechHealthtechMedical DevicesNorthbrook, US

JAJeffrey Aronin(Director)inJMJeffrey M. Dayno, M.D.(President and Chief Executive Officer)inPatrick Morris(Secretary and Treasurer)inRobert Repella(Director and Chief Executive Officer)Darien Parhad(Chief Financial Officer)

BoardARAaron Royston(Director)in

Co-investorsAIAisling CapitalHBHBM Healthcare InvestmentsHBHBM PartnersPAParagon Biosciences LLCPIPivotal Life SciencesVAValor Equity Partners+3 more

Hemab develops targeted therapies for bleeding and clotting disorders such as Glanzmann thrombasthenia, Factor VII deficiency, Von Willebrand Disease, and heavy menstrual bleeding.

BiotechDigital HealthHealthtechMedical Devices

Co-investorsACAccess BiotechnologyAVAvoro Capital AdvisorsHEHealthCapSOSofinnova PartnersRARA Capital

MapLight Therapeutics is a biopharmaceutical company developing targeted treatments for central nervous system disorders through a platform designed to modulate neural circuits implicated in disease.

BiotechRedwood City, US

Anatol Kreitzer(Executive Officer)Kristopher Hanson(Executive Officer)James Lillie(Executive Officer)Jonathan Gillis(Executive Officer)inVSVishwas Setia(Executive Officer)inChristopher A. Kroeger(President, Chief Executive Officer and Director)

Co-investorsAVAvego BioScience CapitalPIPivotal Life SciencesFOForbion

Mirum Pharmaceuticals is a biopharmaceutical company that develops and delivers therapies for people living with rare diseases.

BiotechHealthtechSan Diego, US

CPChris Peetz(Co-founder & Chief Executive Officer)inEBEric Bjerkholt(Executive Officer)inPRPeter Radovich(Executive Officer)in

BoardPHPatrick Heron(Director)inMichael Grey(Director)Timothy Walbert(Director)

Co-investorsCHChiesi VenturesFRFrazier Life SciencesLOLongitude CapitalMEMESA VERDE VENTURE PARTNERSNENew Enterprise Associates (NEA)PAPappas Capital+4 more

Nkarta is a biotech company developing allogeneic CAR NK cell therapies for autoimmune diseases, aiming to offer safer and more accessible alternatives to autologous CAR-T treatments.

BiotechHealthtechSouth San Francisco, US

PHPaul Hastings(Executive Officer, Director)inPaul H.inMatthew Plunkett(Executive Officer)in

BoardMichael Dybbs(Director)JCJill Carroll(Director)inTATiba Aynechi(Director)in

Co-investorsNENew Enterprise Associates (NEA)RARA CapitalSASamsara BioCapitalSRSR One Capital ManagementAMAmgen VenturesLOLogos+1 more

OnKure Therapeutics is a clinical-stage biopharmaceutical company developing PI3Kα pan-mutant selective inhibitor medicines for the treatment of breast cancer and vascular anomalies.

BiotechDigital HealthHealthtechMedical DevicesBoulder, US

JLJason Leverone(Executive Officer)inSASamuel Agresta(Executive Officer)inDHDylan Hartley(Executive Officer)inWendy Johnson(Executive Officer)Nicholas A. Saccomano(President and Chief Executive Officer and Director)

BoardIMIsaac Manke(Director)in

Co-investorsACAccess BiotechnologyBOBoulder VenturesRIRiverVest Venture PartnersABAbingworthACACORN BIOVENTURESNENew Enterprise Associates (NEA)

Praxis Precision Medicines is a central nervous system precision neuroscience biopharmaceutical company developing therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance, with a pipeline spanning movement disorders and epilepsy.

BiotechDeep TechHealthtechBoston, US

SPSteve Petrou(Co-Founder, President of Research & Development)inKRKiran Reddy(Executive Officer, Director)inMarcio Souza(President & Chief Executive Officer)in

BoardNicholas G. Galakatos(Director)in

Co-investorsAVAvoro Capital AdvisorsCACapria VenturesOCOCV PartnersALAlameda ResearchAPAPOLLO PROJECTSBLBlackstone+6 more

Recursion applies computational and data-driven approaches to biological science, aiming to accelerate drug discovery and develop new treatments.

AI & Machine LearningBiotechData & InfrastructureDeep TechMedical DevicesSalt Lake City, US

CGChris Gibson(Co-founder and Chairman of the Board)inBCBlake C. Borgeson(Executive Officer, Director)inDean Y. Yi(Executive Officer, Director)NKNajat Khan(Chief Executive Officer)inNajat Khan, Ph.D.(CEO and President)inBlake Borgeson(Founder)

Co-investorsDCDCVC (Data Collective)LULux CapitalBABaillie GiffordADAdvantage Capital PartnersAIAir Street CapitalAMAmplify Partners+22 more

Spruce Biosciences develops and commercializes therapies for serious neurological and endocrine disorders with unmet medical need, with a lead investigational enzyme replacement therapy (TA-ERT) for Mucopolysaccharidosis Type IIIB (Sanfilippo Syndrome Type B).

BiotechHealthtechSouth San Francisco, US

SGSamir Gharib(Executive Officer)inRICHARD KING(Executive Officer, Director)inJSJavier Szwarcberg(Chief Executive Officer)in

BoardSimpson Camilla(Director)TATiba Aynechi(Director)inBMBali Muralidhar(Director)in

Co-investorsAIAisling CapitalHEHealthCapRIRiverVest Venture PartnersABAbingworthNONorwest Venture PartnersOMOmega Funds+1 more

Biomason uses biotechnology to grow biocement, producing concrete and tile products by using bacteria to bind natural materials as an alternative to Portland cement, aimed at concrete producers and the construction industry.

BiotechClimate TechConstruction TechNew MaterialsResearch Triangle Park, US

GKGinger K. Dosier(Executive Officer, Director)inMichael F. Noel(Director)John M. Dosier(Executive Officer)

Board seatABAnders Bendsen Spohr· per SEC Form D

Co-investorsCACarbonCECelesta Capital

Acesion Pharma is a biotech company developing pharmaceutical treatments.

BiotechHealthtechMedical DevicesCopenhagen, DK

USUlrik Sørensen(COO & Co-founder)inMGMorten Grunnet(CSO & Co-founder)inAGAnders Gaarsdal Holst(CEO & CMO)inTVTorgeir Vaage(CFO)in

Co-investorsALAlpha Wave GlobalCACanaan PartnersBRBroadview VenturesGLGlobal BioAccess Fund

Alentis is a biotech company developing therapies for chronic liver disease, fibrosis, and cancer based on the molecular biology of liver disease.

AI & Machine LearningBiotechHealthtechMedical DevicesBasel, CH

TBThomas Baumert(Founder)inMPMark Pruzanski(Chief Executive Officer)inLMLuigi Manenti(Chief Medical Officer)inJFJon Freve(Chief Financial Officer)inBYBryan Yoon(General Counsel and Chief Administrative Officer)inAVAditya Venugopal(Chief Business Officer)in

Co-investorsAVAvego BioScience CapitalBIBioMedPartnersFRFrazier Life SciencesJEJeito CapitalLOLongitude CapitalOROrbiMed+5 more

Altasciences operates a drug development platform that integrates nonclinical research, bioanalysis, manufacturing, and Phase I/II clinical execution to compress early-stage drug development timelines from industry standards of 27–51 months to as little as 18 months.

BiotechDeep TechEnterprise SoftwareHealthtechMedical DevicesLaval, CA

MRMarie-Hélène Raigneau(Chief Executive Officer)inCKCatherine Konidas(Chief Administrative Officer)inDBDr. Beatrice Setnik(Chief Scientific Officer)DGDr. Gaetano Morelli(Executive Vice President Medical Affairs, Chief Medical Officer)Steve Mason(Co-Chief Operating Officer)inRSRobert Sabelli(Co-Chief Operating Officer)in

Co-investorsKIKilmer GroupSISignet Healthcare Partners

Amass operates an agentic data platform that unifies over 500 million scientific documents — including research literature, patents, clinical trials, regulatory filings, and web sources — into a single engine that returns answers cited to their source.

AI & Machine LearningBiotechData & Infrastructure

AJAlexander Junge(Co-Founder & CTO)inHJHenrik Jensen(Co-Founder & CEO)in

Co-investorsGIGiant Ventures Global LlpKOKost Capital

AMSilk produces biotech-derived silk protein yarns for textile applications including fashion, accessories, and automotive interiors, using fermentation-based bioprocessing instead of traditional sericulture.

Advanced ManufacturingBiotechCircular EconomyCleantechNew MaterialsMunich, DE

Co-investorsATAthosMIMIG Capital AG

AnaCardio is a Swedish clinical-stage biopharmaceutical company developing novel drugs to treat heart failure, with its lead program AC01 in phase 1b/2a clinical development.

BiotechHealthtechMedical DevicesStockholm, SE

Lars H. Lund(Founder)

Co-investors3B3B Future Health FundINIndustrifondenPUPureos BioventuresSOSound Bioventures

AvenCell Therapeutics develops next-generation cell therapies for hard-to-treat cancers, including solid tumors, combining switchable universal CAR-T technology with a CRISPR/Cas9-based allogeneic platform.

BiotechLongevityMedical Devices

ASAndrew Schiermeier(Chief Executive Officer)in

Co-investorsBLBlackstone Life SciencesEIEight Roads VenturesF-F-Prime CapitalNYNYBC Ventures

BMK Genetics develops breeding programs and genetic solutions for salmon farming, offering tailored genetics for both sea-based open net-pen systems and land-based recirculating aquaculture systems.

AgTechBiotechFoodTechBergen, NO

KBKristian Botnen(CEO)in

Booster Therapeutics develops small-molecule medicines that directly activate the cell's 20S proteasome to restore protein quality-control and clear disease-causing proteins, using its structure-based DGRADX platform combining high-throughput screening, X-ray crystallography, and computational tools.

BiotechDeep TechLongevity

DRDiogo R. Feleciano(Co-Founder & CSO)inDJDarci J. Trader(Scientific Co-Founder / Advisor)JRJoão Ribas(Interim-CBO)in

Co-investorsAPApollo Health VenturesKOKorify Capital

Breye Therapeutics is a biopharmaceutical company developing medicines for ophthalmologic and metabolic diseases, leveraging expertise in clinical development, manufacturing, and regulatory pathways.

BiotechMedical Devices

Ulrik Mouritzen(CEO)

Co-investorsSOSound Bioventures

Callio Therapeutics develops next-generation dual-payload antibody-drug conjugates (ADCs) with differentiated payload and linker technologies for targeted cancer treatment.

BiotechMedical DevicesSeattle, US

PIPiers Ingram(President, Co-Founder)inJBJerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)inZachary Hornby(Chief Executive Officer)

Co-investorsOMOmega FundsFRFrazier Life SciencesJEJeito CapitalNONorwest Venture Partners

Chromologics is a Danish biotech company that uses a precision fermentation platform to produce natural food colours, marketed to food and beverage manufacturers as an alternative to synthetic colourants.

BiotechFoodTechNew MaterialsCopenhagen, DK

AOAnders Odum(Founder)inGTGerit Tolborg(Founder)inAnders Ødum(Co-founder & CTO)KBKlaus Bjerrum(CTO & Founder)inChristian H. Steffensen(CEO)inJBJens Bergholdt(CFO)in

Co-investorsBLBlue Horizon CorporationCOCollateral GoodDODoehler VenturesNONordic Foodtech VC

Clever Care is a culturally and linguistically sensitive Medicare Advantage health plan serving Southern California that integrates Eastern and Western medicine approaches.

HealthtechInsurTechSouthern California, US

Myong Sun Lee(Executive Officer, Director)Hiep Dinh Pham(Executive Officer, Director)Dave Firdaus(Executive Officer, Director)

Co-investorsGVGV (Google Ventures)NONorwest Venture PartnersGLGlobal Founders CapitalAVAV8 VenturesFIFigure 8 InvestmentsPRPruVen Capital Partners+1 more

Crystalys Therapeutics is a clinical-stage biopharmaceutical company developing targeted therapies for gout, a chronic metabolic disease caused by elevated uric acid.

BiotechHealthtechMedical DevicesSan Diego, US

JMJames Mackay(President & Chief Executive Officer)inNihar Bhakta(Chief Medical Officer)inAshwin Ram(Chief Operating Officer)inDeAnne Reid(Chief Administrative Officer)in

Co-investorsCACatalys PacificANAN Venture PartnersFRFrazier Life SciencesLILightstone VenturesLOLongwood Fund

Elektrofi is a biotech company developing an ultra-high concentration microparticle formulation platform that enables subcutaneous delivery of biologic medicines such as monoclonal antibodies.

BiotechDeep TechHealthtechMedical DevicesBoston, US

Chase Coffman(Chief Executive Officer & Co-founder)inSam Huang(Director)Jason Norris(Co-founder)Charles L. Cooney(Director)Andrew Goldberg(Director)Constatine Chinoporos(Director)

Co-investorsBIBiotechnology Value FundCACatalio Capital Management, LPCHCharlotte Angel FundGEGeneral CatalystRARA CapitalSRSR One Capital Management+1 more

Engimmune develops soluble TCR therapeutic candidates using AI-guided innovation and protein engineering for oncology and immunotherapy applications.

AI & Machine LearningBiotechDeep Tech

RVRodrigo Vazquez-LombardiinSRSai Reddyin

Co-investorsPUPureos Bioventures

Esco Lifesciences manufactures laboratory equipment, biopharma devices, and IVF medical equipment for clinical, research, and industrial laboratories across more than 100 countries.

Advanced ManufacturingBiotechHardwareHealthtechMedical DevicesSingapore, SG

LLLim Lay Yew(Founder)inLow Yae Foong(Founder)

Co-investorsVIVivo CapitalGIGIC

Expedition Therapeutics is a drug development company focused on advancing therapeutic programs in areas such as CAR-T immunotherapy and oncology.

BiotechHealthtechMedical DevicesSan Francisco, US

Yi Larson(Founder and CEO)GGGeoff Gilmartin(Chief Medical Officer)EHEric Hu(Chief Business Officer)

Co-investorsFOForbionSOSofinnova VenturesSASanofi Ventures

LanzaTech converts carbon-rich gases from industrial sources like steel mills and landfills into fuels and chemicals using synthetic biology.

Circular EconomyCleantechClimate Tech

DJDr. Jennifer Holmgren(CEO)Richard Forster(Founder)Sean Simpson(Founder)

Co-investorsACActivant CapitalKHKhosla VenturesOUOutset VenturesQIQiming Venture PartnersSASaints CapitalWEWestern Technology Investment+2 more

MedGenome provides genetic and molecular diagnostic testing across areas including reproductive care, rare hereditary conditions, oncology, and infectious diseases, and operates a CAP-accredited multiomics laboratory with high-throughput sequencing and a proprietary analytics platform.

BiotechDigital HealthHealthtechMedical DevicesBangalore, IN

Co-investorsSOSofinaATATEL VenturesPEPeak XV PartnersLELeapFrog Investments

MinervaX is a biotech company developing prophylactic vaccines, with therapeutic focus areas including immunology and infectious disease.

BiotechHealthtech

PerBengt(CSO)

Co-investorsADAdjuvant CapitalINIndustrifondenOROrbiMedPUPureos BioventuresSASanofi VenturesSUSunstone Capital+2 more

NMD Pharma is a clinical-stage biotech company developing first-in-class small-molecule therapies that selectively target skeletal muscle to treat rare neuromuscular diseases and age-related conditions.

BiotechDeep TechHealthtechMedical DevicesAarhus, DK

Co-investorsJEJeito CapitalINInkefRORoche Venture FundLULundbeckfonden Ventures

NorthSea Therapeutics is a clinical-stage biopharmaceutical company developing oral fatty acid-derived therapies for liver and metabolic diseases, including intestinal failure-associated liver disease (IFALD), severe hypertriglyceridemia, and MASH.

BiotechDigital HealthHealthtech

Co-investorsNENew Science VenturesVEvenBio PartnersYSYsios CapitalBGBGVBIBioGeneration VenturesSOSofinnova Ventures+1 more

Revagenix is a precision-therapeutics company that develops drugs for serious chronic diseases, starting from the underlying biology and unmet clinical needs.

BiotechDeep TechHealthtechMedical Devices

RCRyan Cirz(Co-founder & CEO)inAMAndrew McCandlish(Co-founder & COO)inPSPeter Smith(Chief Scientific Officer)inDaniel Cloutier(VP, Development)in

Co-investorsTETenmile

Route 92 Medical develops neurointervention catheter systems and devices aimed at improving outcomes for neurovascular patients, including stroke treatment.

BiotechHardwareHealthtechMedical DevicesSan Mateo, US

Dr. Chou(Founder & Chief Executive Officer)CLCindy Lynch(Executive Officer)inDJDr. Joey English(Chief Medical Officer)TCTony Chou(Founder)in

BoardJLJack Lasersohn(Director)inTamir Meiri(Director)

Co-investorsTHThe Vertical GroupNONorwest Venture PartnersRURunway Growth CapitalUSUS Venture PartnersSESectoral Asset ManagementSOSofinnova Ventures+1 more

Sonion designs and manufactures miniaturized audio components and solutions for hearing aids, including microphones, receivers, RIC systems, and sensors.

Deep TechHardwareHealthtechMedical DevicesRoskilde, VN

Co-investorsALAltorTDTDF Ventures

Ritedose is a contract development and manufacturing organization (CDMO) that produces generic and specialty medications using advanced data analysis and custom technology solutions.

Advanced ManufacturingBiotechHealthtechMedical DevicesColumbia, US

JCJody Chastain(Chief Executive Officer)in

Co-investorsOLOlympus Partners

THEVA manufactures high-temperature superconductor wire and related components for industrial, power transmission, and renewable energy applications.

Advanced ManufacturingDeep TechEnergyNew MaterialsGermany, DE

Co-investorsBABayern KapitalENEnBW New Ventures GmbHTATarget Partners

Verana Health aggregates de-identified clinical data from a network of over 20,000 physicians in ophthalmology, urology, and neurology to power real-world evidence, clinical trial enablement, and quality reporting for pharmaceutical companies and healthcare providers using AI and machine learning.

AI & Machine LearningData & InfrastructureDigital HealthHealthtechSan Francisco, US

Mark Blumenkranz, MD(Co-Founder, Verana Health and Lagunita Biosciences)SJSujay Jadhav(Chief Executive Officer)in

Co-investorsBRBreyer CapitalGVGV (Google Ventures)MEMerck Global Health Innovation FundMSMSD Global Health Innovation FundNANat TurnerTETech Council Ventures+3 more

ZELP develops technology to measure and reduce methane emissions from the livestock industry.

AgTechClimate TechImpact & Social GoodIoT

Francisco(Co-Founder, CEO)inPatricio(Co-Founder, Chairman of the Board)

Co-investorsCOCollaborative FundDADanone Manifesto VentureSTStarlight Ventures

HealthtechJacksonville, US

Nathan W. Eastman(Chief Financial Officer, Treasurer)inChristopher Hunter(Director)Steve Betts(Director)Earnie Franklin(Director)Aaron Gani(Director)Carl McDonald(Director)

Board seatALAbhijeet Lele· per SEC Form D

Co-investorsFRFrancisco Partners

Genomatica (Geno) develops biotechnology processes to produce bio-based chemicals and materials—such as 1,4-butanediol (BDO), butylene glycol for cosmetics, and plant-based nylon—as alternatives to fossil-fuel-derived inputs.

BiotechCircular EconomyCleantechClimate TechNew MaterialsSan Diego, US

CSChristophe Schilling(Co-founder (former CEO))inBernhard Palsson(Co-founder)Carlos A. Cabrera(Executive Chairman)inJGJohn G. Gugel(Chief Executive Officer)inTMTom McDonald(SVP, Finance & Chief Financial Officer)inNBNelson Barton(SVP, Research and Development)in

Board seatABAnders Bendsen Spohr· per SEC Form D

Co-investorsTHThule InvestmentsVAVantagePoint Capital PartnersVIViking GlobalCACasdin CapitalDRDraper Fisher Jurvetson (DFJ)MOMohr Davidow Ventures

MycoWorks produces Reishi, a premium biomaterial made from Fine Mycelium, used as a sustainable leather alternative in furniture, design, and automotive products.

BiotechCircular EconomyNew MaterialsEmeryville, US

Philip Ross(Founder)inMichael Lindheim(Executive Officer)MSMatthew Scullin(Executive Officer, Director)inEddie Pavlu(Founder)Phil Ross(Founder)Sophia Wang(Founder)

Board seatABAnders Bendsen Spohr· per SEC Form D

Co-investorsATATEL VenturesDCDCVC (Data Collective)GAGaingelsHEHemisphere Ventures LLCSOSOSVVAValor Equity Partners+9 more

Adcendo develops antibody-drug conjugates (ADCs) targeting cancers with high unmet medical need.

BiotechMedical Devices

Co-investorsVIVida VenturesHEHealthCapJEJeito CapitalOROrbiMedPOPontifax Venture CapitalRARA Capital+3 more

AgNext is a deep-tech company that uses AI, diagnostics, and automation to make food quality measurable in real time, providing objective quality assessment and traceability across procurement, processing, and supply chains.

AgTechAI & Machine LearningFoodTech

Co-investorsALAlpha Wave GlobalKAKalaari Capital

Antag Therapeutics develops GIP receptor antagonist therapies for obesity, diabetes, and overweight patients.

BiotechHealthtechCopenhagen, DK

JJJens Juul Holst(Founder)MRMette Rosenkilde(Founder)in

Co-investorsBRBroadview VenturesSRSR One Capital ManagementVEVersant Ventures

AnywhereCam sells solar-powered 4G/LTE cellular surveillance cameras with pan-tilt-zoom, two-way audio, night vision, and cloud storage that operate off-grid without wired power or Wi-Fi.

ConsumerE-commerceHardwareIoT

Michael Blecha(Founder)in

Co-investorsGRGreater Colorado Venture FundGEGeneral AtlanticHEHercules Capital, Inc.NENew Enterprise Associates (NEA)SOSoftBank GroupSOSoftBank Vision Fund+1 more

Arcellx develops CAR T-cell therapies that are individually designed for each patient, using the immune system to target and attack cancer.

BiotechHealthtechGaithersburg, US

Han Lee(Executive Officer)RERami Elghandour(Executive Officer, Director)in

BoardJCJill Carroll(Director)inABAli Behbahani(Director)inDYDerek Yoon(Director)inTATiba Aynechi(Director)in

Co-investorsLGLG Technology VenturesNENew Enterprise Associates (NEA)QUQuan CapitalSASamsara BioCapitalSISixty Degree CapitalSOSolasta Ventures+4 more

Asgard provides sales intelligence and intent detection data to B2B companies, identifying qualified prospects and their specific needs for targeted sales outreach and account-based marketing campaigns.

AI & Machine LearningData & InfrastructureEnterprise SoftwareSales TechParis, FR

Co-investorsTETechstarsBOBoehringer Ingelheim Venture FundINIndustrifondenRORobot Ventures

Asgard Therapeutics develops direct cell reprogramming technologies that convert cancer cells into dendritic cells to restore anti-cancer immune responses.

AI & Machine LearningBiotechHealthtechMedical DevicesLund, SE

CPCristiana Pires(Co-founder and CEO)inFRFábio Rosa(Co-founder and VP of Research)inFPFilipe Pereira(Co-founder and Head of Innovation)in

Co-investorsINIndustrifondenLULU InnovationRVRV Invest GmbHBOBoehringer Ingelheim Venture Fund

Augustine Therapeutics is a biotech company developing HDAC6-targeted therapies for peripheral neuropathies such as Charcot-Marie-Tooth disease and chemotherapy-induced peripheral neuropathy, as well as neurodegenerative disorders like ALS.

BiotechMedical Devices

Co-investorsADAdBio partnersASAsabys PartnersJEJeito CapitalPMPMVV-V-Bio VenturesNENewton Biocapital

Bactolife develops Binding Proteins for use in functional foods for humans and in animal feed, aimed at supporting healthy digestion and livestock health.

AgTechBiotechFoodTech

Co-investorsCRCross-Border Impact Ventures

BBI Solutions provides reagents and biochemical products for in vitro diagnostics and life sciences teams, supporting assay development and diagnostic test manufacturing.

Advanced ManufacturingBiotechHealthtechMedical Devices

ASAlexander Socarrás(Group CEO)in

BioGeneration Ventures (BGV) is the early-stage arm of the Forbion-BGV platform of funds, investing in and supporting biotech and life sciences companies across their stages of development.

BiotechHealthtechNaarden, NL

Co-investorsBOBOMKFKfW CapitalEUEuropean Investment FundKFKfW

Biosyntia is a Copenhagen-based industrial biotech company that uses strain engineering and fermentation to produce sustainable, bio-based active ingredients like vitamin B7, replacing petrochemical-derived alternatives for cosmetics and nutrition markets.

Copenhagen, DK

Hans Genee(Founder)Morten Sommer(Founder)

Co-investorsEUEuropean Circular Bioeconomy FundSOSofinnova Partners

Bluejay is a biotechnology company focused on therapeutic development.

BiotechSan Mateo, US

KCKeting Chu(Founder, Chief Executive Officer and Chairman of the Board)inDajun Yang(Director)Nancy Hong(Director)inAlon Lazarus(Director)William J. Rutter(Director)Ting Jia(Director)

Co-investorsFRFrazier Life SciencesRARA CapitalRIRiverVest Venture PartnersWEWellington ManagementFRFrazier Healthcare PartnersHBHBM Healthcare Investments+2 more

Activating the immune system to recognize and destroy tumor cells.

BiotechCambridge, US

Art Krieg(Executive Officer, Director)Barry Labinger(Executive Officer, Director)Chuck Abdalian(Executive Officer)David Mauro(Executive Officer)Karen Brennan(Executive Officer)Charles Yon(Executive Officer)

Co-investorsDEDecheng CapitalF-F-Prime CapitalLOLongitude CapitalSOSofinnova VenturesVEvenBio Partners

Cirius Therapeutics is a clinical-stage pharmaceutical company developing therapies for patients with chronic metabolic diseases driven by insulin resistance, including Type 2 Diabetes and obesity.

BiotechDigital HealthGrand Rapids, US

Jerry Callahan(Executive Officer)BFBrian Farmer(Executive Officer)inRobert Baltera(Executive Officer, Director)Howard Dittrich(Executive Officer)

BoardMichael Jandernoa(Director)Mark Olesnavage(Executive Officer)

Co-investorsFRFrazier Life SciencesFRFrazier Healthcare Partners

Claris Bio develops biologic therapies for sight-threatening eye diseases, with a current focus on bringing CSB-001, a novel treatment for patients with limbal stem cell deficiency, through clinical development and to market.

BiotechHealthtechMedical DevicesJersey City, US

CAClarke Atwell(Co-Founder and Chief Operating Officer)inHenry Rath(Executive Officer)SOSusan Orr(Executive Officer)inStephen Brady(Executive Officer, Director)Michael Dybbs(Director)Matt Hobson(Director)

Co-investorsCACatalio Capital Management, LPRARA CapitalSOSofinnova VenturesCACatalio Capital ManagementSASamsara BioCapital

Clasp Therapeutics develops off-the-shelf precision T cell engagers (its proprietary pHLАre molecules) that target mutant peptide-HLA complexes displayed on cancer cells, directing T cells to destroy tumors carrying common driver mutations such as KRas.

BiotechHealthtechCambridge, US

Co-investorsCACatalio Capital Management, LPCUCure VenturesVIVivo CapitalBRBrightEdgeCACatalio Capital ManagementTHThird Rock Ventures

Coave Therapeutics develops targeted gene therapy vectors using its proprietary ALIGATER platform to deliver therapeutic genes to specific tissues with improved safety and precision.

BiotechDeep TechHealthtechMedical DevicesParis, FR

Co-investorsFUFund+KUKurma PartnersSESeroba Life SciencesV-V-Bio VenturesBPBpifranceGOGO Capital+2 more

Commit Biologics develops a complement-targeted drug discovery platform and antibody-based therapeutics for oncology, autoimmune diseases, and infectious disease indications.

BiotechHealthtechMedical DevicesAarhus, DK

Dennis(COO & Co-founder)Nick(Head of Discovery & Co-founder)Mikael(Head of Platform Technology & Co-founder)Heidi(Head of Drug Screening & Co-founder)Thomas(CEO)

Co-investorsKOKorysBIBioqube Ventures

Complement Therapeutics is a clinical-stage biotechnology company developing gene therapies for complement-mediated diseases, with a lead AAV-based candidate (CTx001) for Geographic Atrophy secondary to Age-related Macular Degeneration.

BiotechDigital HealthHealthtechMedical DevicesMunich, DE

RHRafiq Hasan(CEO and Managing Director)inMAMuhammad Ali Memon(Chief Medical Officer)in

Co-investorsBIBioGeneration VenturesCACambridge Innovation CapitalGIGimvHAHadean VenturesSESeroba Life SciencesBGBGV+2 more

Coultreon is a drug discovery and development company that advances small and large molecule therapeutic programmes across various disease areas, combining disease biology expertise with technology platforms.

AI & Machine LearningBiotech

PRPierre Raboisson(Chief Executive Officer Chief Scientific Officer Co-founder)inMDMarie De Vulder(Chief Legal Officer Co-founder)inGPGuy Peeters(Chief Financial Officer Co-founder)inJGJohn-Paul Gallivan(Head of Development Co-founder)inFKFabrice Kolb(Head of Immunology Co-founder)inPieter Peeters(Operating & Technology Officer Co-founder)in

Co-investorsFIFinchley Healthcare VenturesLOLongwood FundLULuma GroupSOSofinnova VenturesBABAM ElevateFOForbion+2 more

Cyteir is a clinical-stage oncology company developing CYT-0851, an oral investigational drug that inhibits monocarboxylate transporters.

BiotechHealthtechCambridge, US

Kevin Mills(Executive Officer, Director)inRGRonald Goldstein(Executive Officer)inDCDonald Corcoran(Executive Officer, Director)inMRMarkus Renschler(Director)in

BoardTimothy Romberger(Director)Barry Mills(Director)

Co-investorsDRDroia VenturesLILightstone VenturesOUOUP (Osage University Partners)SHShah Family OfficeALAlly Bridge GroupDEDe Novo Ventures+3 more

Doctor Anywhere is a technology-driven healthcare company that provides medical care to patients through online and in-person channels.

Digital HealthHealthtechMental Health

Lim Wai Mun(Founder)

Co-investorsOSOSK Ventures InternationalSQSquare Peg Capital

Draupnir Bio develops targeted protein degradation therapies using sortilin-based lysosome targeting chimeras to clear extracellular and membrane-bound protein aggregates in proteinopathies.

BiotechDeep TechMedical DevicesCopenhagen, DK

SGSimon Glerup(Professor)inCamilla Gustafsen(Professor)inPeder Søndergaard Madsen(Professor)Peter Seeberger(Professor)

Co-investorsINInkefGIGilde HealthcareMCMC Healthcare Ventures

Droia Ventures is a specialist venture capital firm investing globally in early-stage drug development companies focused on therapeutics for oncology and genetic disease.

BiotechLeuven, BE

Co-investorsCLClavystBioFRFrazier Life SciencesLILifeArc Ventures

Elo develops plant-based food ingredients and technologies to enhance nutritional value, taste, and climate resilience in everyday foods.

AgTechBiotechClimate TechFoodTechNew MaterialsDurham, US

ToddMFMichele Fite(Executive Officer)inMTMatthew Todd Rands(Executive Officer, Director)CPChloe Pavely(Executive Officer)inMDMatt DiLeo(Director)inPBPaul Boyer(Executive Officer)in

Co-investorsDCDCVC (Data Collective)ACAccelr8DCDCVC BioKDKdT Ventures

Extracellular is a biomanufacturing company that helps cell-based product developers in cultivated meat, plant cell culture, and bioactives accelerate discovery, overcome production challenges, and commercialize their products.

Advanced ManufacturingBiotechFoodTechNew Materials

WMWill Milligan(CEO & Founder)in

Co-investorsBIBig Idea VenturesFFFFFNENewland SyndicateUNUnruly Capital5A5AM VenturesAGAgent Capital+8 more

FIRE1 develops NORM, an implantable sensor placed in the inferior vena cava to directly measure fluid volume in heart failure patients, paired with a self-management platform to help patients engage with their own care.

Digital HealthHardwareMedical DevicesDublin, IE

Co-investorsANAndera PartnersGIGimvIRIreland Strategic Investment FundLILightstone VenturesLOLongitude CapitalNENew Enterprise Associates (NEA)+5 more

Damora Therapeutics is a biotechnology company developing subcutaneous biologics as targeted, disease-modifying treatments for patients with mutant calreticulin (mutCALR)-driven myeloproliferative neoplasms such as essential thrombocythemia and myelofibrosis.

BiotechMedical Devices

JJJennifer Jarrett(Chief Executive Officer & Board Director)inSSSherwin Sattarzadeh(Chief Operating Officer)inBHBecker Hewes(Chief Medical Officer)GWGarrett Winslow(General Counsel)inJBJim Baker(Chief Corporate Affairs Officer)inBBBrian Burkavage(Senior Vice President, Finance)in

Co-investorsEIEIR VenturesHAHadean VenturesM M VenturesSESEED Capital DenmarkSESeventure PartnersSUSunstone Capital+3 more

Genome Medical provides telehealth-enabled genetic services, including genetic counseling, genetic testing, and clinical trial matching, with a focus on individuals with rare conditions.

BiotechDigital HealthHealthtechSouth San Francisco, US

LALisa Alderson(Executive Officer, Director)inRandal Scott(Director)Jill Davies(Executive Officer, Director)inEMElizabeth Moreno(Executive Officer)inMSMark Sylvester(Chief Financial Officer)inAWAndrew Warner(Vice President, Product)in

Co-investorsALAlumni VenturesAVAvestria VenturesCACanaan PartnersDRDreamers VCECEcho Health VenturesGVGV (Google Ventures)+11 more

GlycoEra develops glycan-based therapeutics, applying glycoengineering technology to create biologic drugs.

BiotechHealthtechNewton, US

Ganesh V. Kaundinya(President & CEO)in

Co-investors5A5AM VenturesCACatalio Capital Management, LPLILifeArc VenturesRORoche Venture FundSISixty Degree CapitalSOSofinnova Partners+1 more

Glycomine develops therapeutics for rare diseases, many of which currently lack disease-modifying treatment options.

BiotechSan Francisco, US

Agnes Rafalko(Executive Officer, Director)inSASteven Axon(Chief Executive Officer)inHAHicham Alaoui(Chief Scientific Officer)inRMRose Marino(Chief Medical Officer)inPMPeter McWilliams(Chief Business Officer)GHGeoffrey Hird(Chief Technology Officer)in

Co-investorsADAdvent Life SciencesASAsahi Kasei Corporate Venture CapitalCHChiesi VenturesCTCTI Life Sciences Fund L.P.MIMission Bay CapitalMIMission Biocapital+6 more

HepaRegeniX is a clinical-stage biotech company developing therapies that treat acute and chronic liver diseases by promoting liver regeneration.

BiotechHealthtechTuebingen, DE

Co-investorsCOcoparionBOBoehringer Ingelheim Venture FundHTHTGF

Danish biotech developing non-opioid restorative treatments for chronic pain, hearing loss and sensory neuron disorders.

Co-investorsEIEIR VenturesINIndaco Venture PartnersMEMedical Incubator Japan K.K.

HPNow produces hydrogen peroxide (Peroxide UltraPure) on-site through a patented electrochemical process that converts water, electricity, and air into low-concentration, high-purity peroxide for water treatment.

AgTechCircular EconomyCleantechHardwareNew Materials

Co-investorsAPAP VenturesEVEvonik Venture Capital GmbH

HST Pathways provides an all-in-one technology platform for ambulatory surgery centers (ASCs) that integrates clinical, financial, and operational management.

Digital HealthEnterprise SoftwareHealthtechSaaS

Gavin(Founder)

Co-investorsBABain Capital Tech OpportunitiesBLBlue Hour VenturesBABain Capital

OLG Machinery, founded in 2008, trades new and certified used industrial spare parts and machinery, serving U.S. companies operating across North and South America with a focus on Mexico.

Advanced ManufacturingB2B MarketplacesLogistics & Supply Chain

Co-investorsOXOxford Investment Opportunity Network (OION)ALAlly Bridge GroupALAltium CapitalAMAmgen VenturesDRDroia VenturesFRFrazier Healthcare Partners+2 more

Hummingbird Bioscience is a precision biotherapeutics company developing a pipeline of novel targeted therapies for cancer, using proprietary drug discovery technologies and platforms.

AI & Machine LearningBiotechDeep TechHealthtech

PIPiers Ingram(Chief Executive Officer, Co-Founder, Executive Director)inJBJerome Boyd-Kirkup(Chief Scientific Officer, Co-Founder)inKonrad Paszkiewicz(Chief Technology Officer)inKwek Kon Yew(Chief Medical Officer)DTDipti Thakkar(Chief Operating Officer)in

Co-investorsALAltium CapitalCLClavystBioDEDecheng CapitalDRDroia VenturesFRFrazier Life SciencesKIKiwoom Investment+6 more

Inspirna is a clinical-stage biopharmaceutical company developing novel cancer drugs that target previously undruggable drivers of metastasis using its proprietary miRNA-DRIVEr platform.

BiotechHealthtechMedical DevicesNew York, US

Sohail Tavazoie(Co-Founder & Chair of Scientific Advisory Board)Masoud Tavazoie(Co-Founder & Advisor)in

Co-investorsSOSofinnova PartnersVIVivo CapitalSASands Capital VenturesSTStart Capital

Inventiva is a clinical-stage biopharmaceutical company developing drug candidates, with a focus on liver and other diseases.

BiotechMedical Devices

Co-investorsEUEuropean Investment BankANAndera PartnersCLClaret Capital PartnersNENew Enterprise Associates (NEA)SASamsara BioCapitalSOSofinnova Partners+1 more

Boston, US

Jurgen Horn(Executive Officer, Director)

BoardPhilip Austin(Director)in

Co-investorsF-F-Prime CapitalGVGV (Google Ventures)ANAnterra CapitalCACasdin CapitalEIEight Roads Ventures

Kebotix uses artificial intelligence, machine learning, and laboratory automation to discover and develop new materials and molecules.

AI & Machine LearningDeep TechNew MaterialsCambridge, US

Dennis Sheberla(Executive Officer)inSemion Saykin(Executive Officer)AAAlan Aspuru-Guzik(Executive Officer)inAKAshish Kulkarni(Chairman and CEO)in

BoardTong Hui(Director)AKAndrew Krowne(Director)in

Co-investorsARArcTern VenturesBABantam GroupCOConstructor Capital USEMEmbark VenturesFLFlybridge Capital PartnersONOne Way Ventures+6 more

Kivu Bioscience develops antibody-drug conjugate (ADC) therapeutics in clinical development, advancing a pipeline of cancer treatments through strategic partnerships and collaborations.

BiotechDeep TechHealthtechMedical Devices

MTMohit Trikha(CEO)inSRSophia Randolph(Chief Medical Officer)in

Co-investorsBIBioGeneration VenturesBOBOMGIGimvHEHealthCapM M VenturesRERed Tree Venture

LAVA develops the Gammabody platform, which generates bispecific antibodies that activate gamma-delta T cells to treat cancer by directing immune cells to tumors and triggering anti-cancer immune responses.

AI & Machine LearningBiotechHealthtechMedical Devices

Ton AdanginHVHans van der Vliet(Head of Innovation)inSHSteve Hurly(Chief Executive Officer)OPOxana Polyakova(Chief Scientific Officer)in

Co-investorsMRMRL Ventures FundSASanofi VenturesYSYsios CapitalGIGilde HealthcareREREDMILE

LimmaTech develops vaccine technologies and programs designed to combat antimicrobial-resistant pathogens and prevent severe infections.

AI & Machine LearningBiotechHealthtechMedical Devices

Co-investorsADAdjuvant CapitalANAndera PartnersTETenmile

MDLIVE is a telehealth service offering 24/7 virtual medical appointments by phone or video with a national network of board-certified doctors, dermatologists, psychiatrists, and therapists.

Digital HealthHealthtechMental Health

Co-investorsGRGreat Oaks Venture CapitalHEHealth Velocity CapitalHEHeritage GroupPEPerot JainSISixth StreetINIndustry Ventures+1 more

Metagenomi is a genetic medicines company developing therapies based on gene editing technologies to treat patients with serious diseases.

BiotechDeep TechHealthtechMedical DevicesBerkeley, US

BTBrian Thomas(Founder)inBrian Thomas Jillian Banfield(Founder)Jill Banfield(Founder)Jian Irish(President and CEO)

BoardAFAndrew Farquharson(Director)inJak Knowles(Director)

Co-investorsCACatalio Capital Management, LPRARA CapitalSOSozo VenturesAGAgent CapitalFRFrazier Life SciencesHUHumboldt+5 more

Myricx Bio is a biotech company developing antibody drug conjugates (ADCs) based on N-myristoyltransferases (NMT) inhibitors for cancer treatment.

BiotechMedical DevicesLondon, GB

Co-investorsBRBrandon Capital PartnersSOSofinnova PartnersABAbingworth

BiotechBoston, US

David Donabedian(Executive Officer, Director)inRHRobert Hadfield(Executive Officer)inJMJohn McCabe(Executive Officer)in

BoardCWChristoph Westphal(Director)Ming Cheah(Director)inRCRaymond Camahort(Director)

Co-investorsDCDCVC (Data Collective)DCDCVC BioARArkin CapitalLOLongwood Fund

Novo Nordisk is a pharmaceutical company that develops and markets treatments for conditions including diabetes, obesity/weight management, and haemophilia, with products such as GLP-1 therapies.

BiotechHealthtechCopenhagen, DK

MMMaziar Mike Doustdarin

Co-investorsHMHM Venture Partners

Novonesis develops biological solutions for agriculture, animal feed, food production, and consumer products, helping customers improve crop yields, product quality, and sustainability.

AgTechBiotechClimate TechFoodTechCopenhagen, DK

Numab develops multispecific antibody-based therapeutics using its proprietary λ-Cap and MATCH discovery and engineering platforms, aiming to improve on first-generation antibody therapies in potency, stability, effect duration, and safety.

BiotechDeep Tech

DUDavid Urech(Founder)in

Co-investorsEIEisai Innovation, Inc.HBHBM Healthcare InvestmentsHBHBM PartnersBIBiotechnology Value FundBLBlackRockFOForbion+1 more

Nuvig Therapeutics is a biotech company developing immune-modulating therapies for autoimmune and chronic inflammatory diseases, using an endogenous regulatory mechanism intended to treat inflammation without compromising broader immune function.

BiotechLongevity

Co-investorsSASanofi VenturesABabrdn plcALAlexandriaB B CapitalDIDigitalis VenturesGLGlobal BioAccess Fund+4 more

Octave is a mental health practice platform that connects licensed therapists with patients seeking in-network mental health care.

Digital HealthHealthtechMental HealthSaaSSan Francisco, US

SASandeep Acharya(Founder, CEO)inDWDavid White(Executive Officer)in

BoardSBSaurabh Bhansali(Director)inEllie Wheeler(Director)Craig Cimini(Director)

Co-investorsFEFelicis VenturesGRGreycroftHEHealthier CapitalNANat TurnerOBObvious VenturesCOCompany Ventures+3 more

Orbis Medicines is a drug discovery company developing orally bioavailable macrocycle drug candidates as alternatives to injectable biologics, targeting both intracellular and extracellular protein targets.

AI & Machine LearningBiotechDeep Tech

Co-investorsNENew Enterprise Associates (NEA)FOForbionLILilly Ventures

Oxford Biomedica is a biopharmaceutical contract development and manufacturing organization (CDMO) specializing in cell and gene therapies, lentiviral vector technologies, and bioprocessing solutions.

Advanced ManufacturingBiotechDeep TechHealthtechMedical DevicesOxford, GB

DFDr. Frank Mathias(Chief Executive Officer)inDLDr. Lucinda Crabtree(Chief Financial Officer)

BoardDr. Roch Doliveux(Non-Executive Chair)

Co-investorsOBOberland Capital

Teambit analyzes code, meeting time, and interactions to measure and improve the performance of software development teams, delivering objective metrics.

AI & Machine LearningDeveloper ToolsSaaS

PEPaula Enei(Founder)in

Co-investorsGGGG Capital4B4BIO CapitalDEDeerfield Management CompanyGEGeneral CatalystMRMRL Ventures FundNONorwest Venture Partners

HealthtechHouston, US

Jonathan P. Otterstatter(Executive Officer, Director)Larry Lawson(Executive Officer, Director)John Untereker(Executive Officer)

BoardWilliam Taranto(Director)Joseph Volpe(Director)

Co-investorsARArthur VenturesMEMerck Global Health Innovation FundSASamsung Catalyst FundVIVivo Capital

Qure.ai builds deep learning and AI software to detect and manage diseases such as lung cancer, tuberculosis, pediatric TB, and stroke, with several FDA-cleared solutions.

AI & Machine LearningDigital HealthHealthtechMedical DevicesNew York, US

Prashant Warier(Founder)Pooja Rao(Founder)

Co-investorsCRCrane Venture PartnersHEHealthQuadLILightspeed India PartnersLILightspeed Venture PartnersMEMerck Global Health Innovation FundMSMSD Global Health Innovation Fund+6 more

Rappta Therapeutics develops small molecule compounds that reactivate protein phosphatase 2A (PP2A) to treat cancer by restoring the enzyme's tumor suppressor function.

AI & Machine LearningBiotechHealthtechMedical Devices

Co-investorsADAdvent Life SciencesNONovartis Venture Fund

Ray Therapeutics develops optogenetics gene therapy treatments for blinding diseases using advanced biotechnology.

BiotechDigital HealthHealthtechMedical Devices

Paul Bresge(Co-founder & Chief Executive Officer)

Co-investorsNONorwest Venture Partners

Reunion Neuroscience is a clinical-stage biopharmaceutical company developing serotonergic psychedelic therapies for mental health conditions such as postpartum depression, adjustment disorder, and generalized anxiety disorder.

BiotechDigital HealthMental HealthMorristown, US

Sahil V. Kirpekar(President and CEO)inGregory Mayes(Executive Officer, Director)ELEllen Lubman(Director)MPMark Pollack(Executive Officer)inNBNathan Bryson(Executive Officer)inMTMark Theeuwes(Executive Officer)in

Co-investorsFEFemHealth VenturesMIMitsui Global InvestmentMPMPM BioImpactPAPalo Santo VC

Rondo Therapeutics is an immuno-oncology biopharmaceutical company developing bispecific/multispecific antibody therapeutics designed for tumor-selective targeting to treat solid tumors while sparing healthy tissue.

BiotechHealthtech

SFShelley Force Aldred(Co-Founder & Chief Executive Officer)inNTNathan Trinklein(Co-Founder, President & CSO)inKatherine(Chief Development Officer)Thomas(Chief Medical Officer)

Co-investorsCACanaan PartnersDEDementia Discovery FundRERed Tree VentureSVSV Health InvestorsJOJohnson & Johnson Innovation – JJDC

Sidera Bio is a biotechnology company using human genetics to develop new medicines for patients.

Biotech

Co-investorsCACatalio Capital Management, LPRARA CapitalFOForbion

Sparrow Quantum develops quantum computing technology, building on research from the Niels Bohr Institute in Copenhagen where the company originated.

Deep TechHardwareQuantum ComputingCopenhagen, DK

Peter Lodahl(Founder)

Co-investorsLILIFTTSCScale Capital2X2xNBABalderton CapitalEUEuropean Investment Bank

Subra develops scalable superconductor solutions aimed at improving energy transmission and infrastructure.

CleantechDeep TechEnergy

Co-investorsENEnBW New Ventures GmbH

Supira Medical develops a next-generation percutaneous ventricular assist device (pVAD) to provide temporary mechanical circulatory support for high-risk patients undergoing coronary interventions and those in cardiogenic shock.

HardwareHealthtechMedical DevicesCampbell, US

NSNitin Salunke(President & CEO)inJean Orth(Executive Officer)MMMariam Maghribi(Executive Officer, Director)

BoardCasey Gordon(Director)Christopher Shen(Director)Bihua Chen(Director)

Co-investors41415 CapitalAMAmed VenturesTHThe Capital PartnershipUNUnorthodox VenturesQAQatar Investment Authority

Terremoto Biosciences is a clinical-stage biotech developing precision therapies for oncology and genetic diseases using lysine-targeted covalent chemistry.

BiotechDeep TechSouth San Francisco, US

Grace Lu(Executive Officer)James Christensen(Executive Officer, Director)Charles Baum(Executive Officer, Director)in

BoardMichael Goller(Director)RHReid Huber(Director)inPTPeter Thompson(Director)in

Co-investorsECEcoR1 CapitalOROrbiMedRARA CapitalTHThird Rock Ventures

The Protein Brewery develops FERMOTEIN, a fermentation-based whole food ingredient made from fungal mycelium that provides complete protein and prebiotic fiber.

BiotechFoodTechBreda, NL

TBThijs Bosch(CEO)in

Co-investorsBOBOMUNUnovis Asset ManagementINInvest-NL

Tribune Therapeutics is a preclinical biopharmaceutical company developing medicines that target CCN protein family signaling (such as CCN2/CTGF) to block fibrotic pathways.

BiotechHealthtech

OKOle Kaasbøll(Co-founder)

Co-investorsHEHealthCapINIndustrifondenINInnovestor VenturesLILifeArc VenturesINInvestinor

WCG advances clinical trial efficiency and outcomes through research services and advisory support.

AI & Machine LearningBiotechDigital HealthEnterprise SoftwareHealthtechMedical DevicesSaaS

Co-investorsLELeonard Green

Windward Bio is a clinical-stage biotechnology company developing long-acting monoclonal and bispecific antibodies for serious immunological conditions such as asthma, COPD, and dermatological diseases.

BiotechHealthtech

Co-investorsOROrbiMedQUQuan CapitalRARA CapitalSASanofi VenturesSRSR One Capital ManagementJAJanus Henderson Investors+3 more